Stakeholders Line Up Lobbying Priorities For Next Two Years

By Cara Smith / January 3, 2023 at 5:00 PM
While the telehealth community celebrates the two-year extension of most COVID-19 pandemic telehealth waivers making it into the year-end budget package, lobbyists are already strategizing their push for permanent telehealth reforms as well as a more immediate push for provisions that did not make it into the spending bill. Lobbyists say three key provisions that were left out of the omnibus funding package will be at the top of their agenda in early 2023: the prescription of controlled substances...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.